• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Charles Bane on the Impact of Rising Expenditures on Practices

Video

The increase in medical expenditures and the move to new care models in oncology will necessitate a change in culture for practice staff, said Charles Bane, MD, Dayton Physicians Network in Ohio.

The increase in medical expenditures and the move to new care models in oncology will necessitate a change in culture for practice staff, said Charles Bane, MD, Dayton Physicians Network in Ohio.

Transcript (slightly modified)

Physicians are increasingly aware of the economics of healthcare and the impact on their practice and their patients. What is your current perception of the healthcare landscape today and the impact on your practice?

The increase in medical expenditures have been rising at such an alarming rate that it's clear that that's not sustainable and so any opportunities there are to reduce total healthcare costs are certainly things to consider or embrace when possibly.

What are some changes in your practice that are required to meer the standards of the Oncology Medical Home model?

The central core aspect of the Oncology Medical Home is making the care really about the patient and what they need. So providing enhanced access to care so that patients who are having issues can be seen by their primary oncologist and deal with those issues in a setting that is familiar to them, which is highly efficient and much less expensive than seeking care at emergency departments or acute care hospitals.

What were the major challenges you had to overcome and how did you prepare your staff for that?

Changing the culture so we're readily available to patients whenever they need us is different than the usual approach. In the past there has been a tendency toward controlling the schedule. So having a specific number of appointments available for a set number of people. So being more flexible, providing more opportunity to add additional people to the schedule to see people on a walk-in basis or a more emergent or unscheduled basis was a major change in culture and approach for our practice.

Related Videos
Joshua K. Sabari, MD
Nicoletta Colombo, MD, PhD
Khush Kharidia, MD
Jo Varshney, PhD, DVM, CEO and founder, VeriSIM Life
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Harry Travis, BS Pharm, MBA, president at The Travis Group, LLC
 Brigid Groves, PharmD, MS, vice president, professional affairs, American Pharmacists Association
Chelsea Renfro, PharmD, research and engagement pharmacist, Vanderbilt Specialty Pharmacy
Marc S. Raab, MD, PhD, University Hospital Heidelberg
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.